Glutamate Metabotropic Receptor 7 (GRM7) Antibody

Este producto es parte de GRM - Glutamate Receptor Metabotropic
Product Graph
442€ (200 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Glutamate Metabotropic Receptor 7 (GRM7) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx431035
tested applications
P-ELISA, WB

Description

GRM7 Antibody is a Goat Polyclonal antibody against GRM7.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Target: Glutamate Metabotropic Receptor 7 (GRM7)
Immunogen: abx615858 - Internal region: NCKLTISGSKKEDT
Host
Goat
Reactivity
Human
Assay Type
Concentration: 0.5 mg/ml
Recommended Dilution
P-ELISA: 1/32000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Size 1
200 µl
Form
Liquid
Tested Applications
P-ELISA, WB
Buffer
Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
2917, 108073, 81672
NCBI Accession
NP_000835.1, NP_870989.1
Alias
GRM7,GLUR7,GPRC1G,MGLU7,MGLUR7,NEDSHBA,PPP1R87, mGluR7,mGlu7a receptor
Background
Antibody anti-GRM7
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

GRM7, or mGluR7, is a Group III metabotropic glutamate receptor widely expressed in the central nervous system, including the hippocampus, amygdala, and cerebellum. It functions as a presynaptic autoreceptor, coupling to Gi/o proteins to inhibit adenylate cyclase, decrease cAMP production, and suppress glutamate release. GRM7 plays a key role in synaptic plasticity, neuroprotection, and neuronal excitability, contributing to learning, memory, and emotional regulation. Dysregulation of GRM7 signaling is linked to psychiatric and neurological disorders, including anxiety, depression, schizophrenia, and epilepsy, where imbalanced glutamatergic transmission disrupts synaptic function. GRM7 activation has neuroprotective effects, reducing excitotoxicity and oxidative stress in neurodegenerative conditions. Positive allosteric modulators (PAMs) and selective agonists of GRM7 are being explored as therapeutic agents for anxiety, mood disorders, and epilepsy, highlighting its potential in restoring synaptic balance and neuroprotection.

Related Products

abx615858

Glutamate Metabotropic Receptor 7 (GRM7) Peptide

Glutamate Metabotropic Receptor 7 (GRM7) Peptide is a synthetic peptide. This peptide is used in the production of

Ver Producto